According to the company, about 70% of the safety mode events occurred during a patient’s clinic visit, while the device was connected to a Latitude programmer. Boston Scientific said it is ...

The Accolade pacemaker system. [Image from Boston Scientific] The FDA today issued an alert after Boston Scientific (NYSE: BSX) + warned of the potential need for the early replacement of certain ...

The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial fibrillation. No hardware is being removed from use—instead, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Truist raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 in Medical Technology.

Dec 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's (BSX.N), opens new tab catheters used in a type of minimally invasive surgery as ...

Boston Scientific has updated the instructions for its Polarx and Polarx FIT cryoablation balloon catheters, the Food and Drug Administration said Wednesday. The update followed a higher than expected ...

Boston Scientific Corporation (BSX), headquartered in Marlborough, Massachusetts, develops, manufactures, and markets medical devices for use in various interventional medical specialties globally.

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific has recalled a group of Accolade pacemakers because of a malfunction that can permanently ...